The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
The Exopolysaccharide Alginate Protects Pseudomonas aeruginosa Biofilm Bacteria from IFN-γ-Mediated Macrophage Killing
Abstract
The ability of Pseudomonas aeruginosa to form biofilms and cause chronic infections in the lungs of cystic fibrosis patients is well documented. Numerous studies have revealed that P. aeruginosa biofilms are highly refractory to antibiotics. However, dramatically fewer studies have addressed P. aeruginosa biofilm resistance to the host’s immune system. In planktonic, unattached (nonbiofilm) P. aeruginosa, the exopolysaccharide alginate provides protection against a variety of host factors yet the role of alginate in protection of biofilm bacteria is unclear. To address this issue, we tested wild-type strains PAO1, PA14, the mucoid cystic fibrosis isolate, FRD1 (mucA22+), and the respective isogenic mutants which lacked the ability to produce alginate, for their susceptibility to human leukocytes in the presence and absence of IFN-γ. Human leukocytes, in the presence of recombinant human IFN-γ, killed biofilm bacteria lacking alginate after a 4-h challenge at 37°C. Bacterial killing was dependent on the presence of IFN-γ. Killing of the alginate-negative biofilm bacteria was mediated through mononuclear cell phagocytosis since treatment with cytochalasin B, which prevents actin polymerization, inhibited leukocyte-specific bacterial killing. By direct microscopic observation, phagocytosis of alginate-negative biofilm bacteria was significantly increased in the presence of IFN-γ vs all other treatments. Addition of exogenous, purified alginate to the alginate-negative biofilms restored resistance to human leukocyte killing. Our results suggest that although alginate may not play a significant role in bacterial attachment, biofilm development, and formation, it may play an important role in protecting mucoid P. aeruginosa biofilm bacteria from the human immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“P. aeruginosa produces three main exopolysaccharides (EPS): alginate, Pel, and Psl, which form the extracellular matrix in the biofilm and have a structural and protective function (Leid et al., 2005; Ryder et al., 2007; Colvin et al., 2011, 2012).”
From In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. (2017) · cites this paper as Leid et al., 2005
In the citing paper
“The switch to a mucoid phenotype contributes to the establishment of chronic colonization since alginate offers structural protection against uptake by macrophages and antimicrobials by forming a barrier limiting the penetration of antimicrobials, macrophages and macrophage-derived products, such as the pro-phagocytic cytokine IFN-γ (Leid et al., 2005; Ryder et al., 2007).”
From In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. (2017) · cites this paper as Leid et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Antibiotic resistance of bacteria in biofilms
Stewart, P. S., & William Costerton, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05321-1 · Cited by 4,585
Mechanisms of biofilm resistance to antimicrobial agents
Mah, T.-F. C., & O'Toole, G. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01913-2 · Cited by 3,921
Biofilm formation as microbial development
O'Toole, G., Kaplan, H. B., & Kolter, R. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.49 · Cited by 3,571
O'Toole, G. A., & Kolter, R. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00797.x · Cited by 2,537
Christensen, G. D., Simpson, W. A., Younger, J. J., Baddour, L. M., Barrett, F. F., Melton, D. M., & Beachey, E. H. (1985) · Journal of Clinical Microbiology · doi:10.1128/jcm.22.6.996-1006.1985 · Cited by 2,255
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
Govan, J. R. W., & Deretic, V. P. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.3.539-574.1996 · Cited by 1,812
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Bacterial Biofilms: An Emerging Link to Disease Pathogenesis
Parsek, M. R., & Singh, P. K. (2003) · Annual Review of Microbiology · doi:10.1146/annurev.micro.57.030502.090720 · Cited by 1,562
Self-citationQuorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
Singh, P. K., Schaefer, A. L., Parsek, M. R., Moninger, T. O., Welsh, M. J., & Greenberg, E. P. (2000) · Nature · doi:10.1038/35037627 · Cited by 1,519
Self-citationMechanisms of antibiotic resistance in bacterial biofilms
Stewart, P. S. (2002) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00196 · Cited by 1,385
Common Virulence Factors for Bacterial Pathogenicity in Plants and Animals
Rahme, L. G., Stevens, E. J., Wolfort, S. F., Shao, J., Tompkins, R. G., & Ausubel, F. M. (1995) · Science · doi:10.1126/science.7604262 · Cited by 1,339
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
Mah, T.-F., Pitts, B., Pellock, B., Walker, G. C., Stewart, P. S., & O'Toole, G. A. (2003) · Nature · doi:10.1038/nature02122 · Cited by 1,190
Spoering, A. L., & Lewis, K. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6746-6751.2001 · Cited by 902
Alginate Overproduction Affects Pseudomonas aeruginosa Biofilm Structure and Function
Hentzer, M., Teitzel, G. M., Balzer, G. J., Heydorn, A., Molin, S., Givskov, M., & Parsek, M. R. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5395-5401.2001 · Cited by 693
Self-citationLam, J., Chan, R., Lam, K., & Costerton, J. W. (1980) · Infection and Immunity · doi:10.1128/iai.28.2.546-556.1980 · Cited by 649
Mathee, K., Ciofu, O., Sternberg, C., Lindum, P. W., Campbell, J. I. A., Jensen, P., Johnsen, A. H., Givskov, M., Ohman, D. E., Søren, M., et al. (1999) · Microbiology · doi:10.1099/13500872-145-6-1349 · Cited by 484
Wozniak, D. J., Wyckoff, T. J. O., Starkey, M., Keyser, R., Azadi, P., O'Toole, G. A., & Parsek, M. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1231792100 · Cited by 466
Self-citationHuman Leukocytes Adhere to, Penetrate, and Respond to Staphylococcus aureus Biofilms
Leid, J. G., Shirtliff, M. E., Costerton, J. W., & Stoodley, A. P. (2002) · Infection and Immunity · doi:10.1128/iai.70.11.6339-6345.2002 · Cited by 401
Self-citationJesaitis, A. J., Franklin, M. J., Berglund, D., Sasaki, M., Lord, C. I., Bleazard, J. B., Duffy, J. E., Beyenal, H., & Lewandowski, Z. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4329 · Cited by 368
and the in vitroand in vivo biofilm mode of growth
Høiby, N., Krogh Johansen, H., Moser, C., Song, Z., Ciofu, O., & Kharazmi, A. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(00)01349-6 · Cited by 356
Role of Biofilms in Antimicrobial Resistance
Donlan, R. M. (2000) · ASAIO Journal · doi:10.1097/00002480-200011000-00037 · Cited by 351
Cystic fibrosis pathogenesis and the role of biofilms in persistent infection
Costerton, J. W. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01918-1 · Cited by 331
Gilbert, P., Allison, D. G., & McBain, A. J. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.5.x · Cited by 323
Govan, J. R. W., & Fyfe, J. A. M. (1978) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/4.3.233 · Cited by 228
Ohman, D. E., & Chakrabarty, A. M. (1981) · Infection and Immunity · doi:10.1128/iai.33.1.142-148.1981 · Cited by 213
Matz, C., Bergfeld, T., Rice, S. A., & Kjelleberg, S. (2004) · Environmental Microbiology · doi:10.1111/j.1462-2920.2004.00556.x · Cited by 200
Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response
Pedersen, S. S., Kharazmi, A., Espersen, F., & Høiby, N. (1990) · Infection and Immunity · doi:10.1128/iai.58.10.3363-3368.1990 · Cited by 177
Moser, C., Kjaergaard, S., Pressler, T., Kharazmi, A., Koch, C., & Høiby, N. (2000) · APMIS · doi:10.1034/j.1600-0463.2000.d01-64.x · Cited by 169
Hypochlorite scavenging by Pseudomonas aeruginosa alginate
Learn, D. B., Brestel, E. P., & Seetharama, S. (1987) · Infection and Immunity · doi:10.1128/iai.55.8.1813-1818.1987 · Cited by 150
Bragonzi, A., Worlitzsch, D., Pier, G. B., Timpert, P., Ulrich, M., Hentzer, M., Andersen, J. B., Givskov, M., Conese, M., & Döring, G. (2005) · The Journal of Infectious Diseases · doi:10.1086/431516 · Cited by 141
A critical concentration of neutrophils is required for effective bacterial killing in suspension
Li, Y., Karlin, A., Loike, J. D., & Silverstein, S. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122244799 · Cited by 130
Meluleni, G. J., Grout, M., Evans, D. J., & Pier, G. B. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.2029 · Cited by 130
Antibiotic Treatment of Multidrug-Resistant Organisms in Cystic Fibrosis
Conway, S. P., Brownlee, K. G., Denton, M., & Peckham, D. G. (2003) · American Journal of Respiratory Medicine · doi:10.1007/bf03256660 · Cited by 127
Moser, C. E., Jensen, P. Ø., Kobayashi, O., Hougen, H. P., Song, Z., Rygaard, J., Kharazmi, A., & Høby, N. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01731.x · Cited by 124
Rosenfeld, M., Ramsey, B. W., & Gibson, R. L. (2003) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-200311000-00008 · Cited by 124
Anaerobic production of alginate by Pseudomonas aeruginosa: alginate restricts diffusion of oxygen
Hassett, D. J. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.24.7322-7325.1996 · Cited by 122
Self-citationMucoid Pseudomonas aeruginosa Resists Nonopsonic Phagocytosis by Human Neutrophils and Macrophages
Cabral, D. A., Loh, B. A., & Speert, D. P. (1987) · Pediatric Research · doi:10.1203/00006450-198710000-00013 · Cited by 106
Pier, G. B., Boyer, D. M., Preston, M. J., Coleman, F. T., Llosa, N. J., Mueschenborn-Koglin, S., Theilacker, C., Goldenberg, H. B., Uchin, J., Priebe, G. P., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5671 · Cited by 101
Diagnosis and Treatment of Cystic Fibrosis
Koch, C., & Høiby, N. (2000) · Respiration · doi:10.1159/000029503 · Cited by 96
Irvin, R. T., Govan, J., Fyfe, J., et al. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.19.6.1056 · Cited by 78
Song, Z., Wu, H. W., Ciofu, O., et al. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05122-0 · Cited by 78
Krieg, D., Helmke, R. J., German, V. F., & MANGOS, J. A. (1988) · Infection and Immunity · doi:10.1128/iai.56.12.3173-3179.1988 · Cited by 67
Oliver, A., & Weir, D. M. (1985) · PubMed · Cited by 40
Persistent infections and immunity in cystic fibrosis
Yu, H. D. (2002) · Frontiers in bioscience · doi:10.2741/a787 · Cited by 33
Anaerobic Biofilm Infections in Cystic Fibrosis
Costerton, J. W. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00698-6 · Cited by 33
Dasgupta, M., ZUBERBUHLER, P., Abbi, A., et al. (1987) · Journal of Clinical Immunology · doi:10.1007/bf00915425 · Cited by 29
Immune-based Novel Therapies for Chronic Hepatitis C Virus Infection
Kakimi, K. (2003) · Human Cell · doi:10.1111/j.1749-0774.2003.tb00153.x · Cited by 9
Cited by
Evolving concepts in biofilm infections
Hall-Stoodley, L., & Stoodley, P. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01323.x · Cited by 1,136
Tolerance and resistance of microbial biofilms
Ciofu, O., Moser, C., Jensen, P. Ø., & Høiby, N. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00682-4 · Cited by 1,124
Kostakioti, M., Hadjifrangiskou, M., & Hultgren, S. J. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a010306 · Cited by 999
Bacterial Extracellular Polysaccharides in Biofilm Formation and Function
Limoli, D. H., Jones, C. J., & Wozniak, D. J. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0011-2014 · Cited by 924
Bjarnsholt, T., Alhede, M., Alhede, M., Eickhardt-Sørensen, S. R., Moser, C., Kühl, M., Jensen, P. Ø., & Høiby, N. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.06.002 · Cited by 764
Metadata
- Authors
- Leid, J. G., Willson, C. J., Shirtliff, M. E., Hassett, D. J., Parsek, M. R., & Jeffers, A. K.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-12-01
- Volume
- 175
- Issue
- 11
- Pages
- 7512-7518
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2163803918
- Cited by
- 525
- References
- 49
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.